256 related articles for article (PubMed ID: 20851716)
1. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.
Kato D; Era S; Watanabe I; Arihara M; Sugiura N; Kimata K; Suzuki Y; Morita K; Hidari KI; Suzuki T
Antiviral Res; 2010 Nov; 88(2):236-43. PubMed ID: 20851716
[TBL] [Abstract][Full Text] [Related]
2. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
Abd-Jamil J; Cheah CY; AbuBakar S
Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
[TBL] [Abstract][Full Text] [Related]
3. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
4. 3-O-sulfated glucuronide derivative as a potential anti-dengue virus agent.
Hidari KI; Ikeda K; Watanabe I; Abe T; Sando A; Itoh Y; Tokiwa H; Morita K; Suzuki T
Biochem Biophys Res Commun; 2012 Aug; 424(3):573-8. PubMed ID: 22776202
[TBL] [Abstract][Full Text] [Related]
5. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.
Alen MM; Kaptein SJ; De Burghgraeve T; Balzarini J; Neyts J; Schols D
Virology; 2009 Apr; 387(1):67-75. PubMed ID: 19264337
[TBL] [Abstract][Full Text] [Related]
7. Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production.
Limjindaporn T; Wongwiwat W; Noisakran S; Srisawat C; Netsawang J; Puttikhunt C; Kasinrerk W; Avirutnan P; Thiemmeca S; Sriburi R; Sittisombut N; Malasit P; Yenchitsomanus PT
Biochem Biophys Res Commun; 2009 Feb; 379(2):196-200. PubMed ID: 19105951
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of chondroitin sulfate type E on the binding step of human T-cell leukemia virus type 1.
Jinno-Oue A; Tanaka A; Shimizu N; Mori T; Sugiura N; Kimata K; Isomura H; Hoshino H
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):621-9. PubMed ID: 23033806
[TBL] [Abstract][Full Text] [Related]
9. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.
Talarico LB; Pujol CA; Zibetti RG; Faría PC; Noseda MD; Duarte ME; Damonte EB
Antiviral Res; 2005 Jun; 66(2-3):103-10. PubMed ID: 15911027
[TBL] [Abstract][Full Text] [Related]
10. [Selection of heparin-sensitive dengue virus variants in BHK-21 cells].
Celis A; Moros Z; Gerder M; Pagano F; Vizzi E; Liprandi F
Invest Clin; 2014 Jun; 55(2):155-67. PubMed ID: 24974631
[TBL] [Abstract][Full Text] [Related]
11. A small molecule fusion inhibitor of dengue virus.
Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the steps involved in Dengue virus entry into host cells.
Hung SL; Lee PL; Chen HW; Chen LK; Kao CL; King CC
Virology; 1999 Apr; 257(1):156-67. PubMed ID: 10208929
[TBL] [Abstract][Full Text] [Related]
13. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.
Alen MM; Dallmeier K; Balzarini J; Neyts J; Schols D
Antiviral Res; 2012 Dec; 96(3):280-7. PubMed ID: 23124109
[TBL] [Abstract][Full Text] [Related]
14. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
[TBL] [Abstract][Full Text] [Related]
15. An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection.
Talarico LB; Duarte ME; Zibetti RG; Noseda MD; Damonte EB
Planta Med; 2007 Nov; 73(14):1464-8. PubMed ID: 17948168
[TBL] [Abstract][Full Text] [Related]
16. Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors.
Marks RM; Lu H; Sundaresan R; Toida T; Suzuki A; Imanari T; Hernáiz MJ; Linhardt RJ
J Med Chem; 2001 Jun; 44(13):2178-87. PubMed ID: 11405655
[TBL] [Abstract][Full Text] [Related]
17. Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry.
Gao F; Duan X; Lu X; Liu Y; Zheng L; Ding Z; Li J
Biochem Biophys Res Commun; 2010 Jan; 391(1):952-7. PubMed ID: 19962368
[TBL] [Abstract][Full Text] [Related]
18. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
19. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.
Mondotte JA; Lozach PY; Amara A; Gamarnik AV
J Virol; 2007 Jul; 81(13):7136-48. PubMed ID: 17459925
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
Rees CR; Costin JM; Fink RC; McMichael M; Fontaine KA; Isern S; Michael SF
Antiviral Res; 2008 Nov; 80(2):135-42. PubMed ID: 18606464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]